These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 30933267)

  • 1. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.
    Mo S; Dai W; Xiang W; Li Y; Feng Y; Zhang L; Li Q; Cai G
    Carcinogenesis; 2019 Jul; 40(7):861-870. PubMed ID: 30933267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value of early relapse in colon cancer.
    Dai W; Feng Y; Mo S; Xiang W; Li Q; Wang R; Xu Y; Cai G
    Carcinogenesis; 2018 Oct; 39(10):1235-1244. PubMed ID: 29982331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma.
    Cai J; Tong Y; Huang L; Xia L; Guo H; Wu H; Kong X; Xia Q
    Carcinogenesis; 2019 Jul; 40(7):840-852. PubMed ID: 31059567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A robust gene signature for the prediction of early relapse in stage I-III colon cancer.
    Dai W; Li Y; Mo S; Feng Y; Zhang L; Xu Y; Li Q; Cai G
    Mol Oncol; 2018 Apr; 12(4):463-475. PubMed ID: 29377588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a novel epigenetic signature for predicting prognosis in colon cancer.
    Luo D; Liu Q; Shan Z; Cai S; Li Q; Li X
    J Cell Physiol; 2020 Nov; 235(11):8714-8723. PubMed ID: 32329069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.
    Di Narzo AF; Tejpar S; Rossi S; Yan P; Popovici V; Wirapati P; Budinska E; Xie T; Estrella H; Pavlicek A; Mao M; Martin E; Scott W; Bosman FT; Roth A; Delorenzi M
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25246611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.
    Tian X; Zhu X; Yan T; Yu C; Shen C; Hu Y; Hong J; Chen H; Fang JY
    Mol Oncol; 2017 Nov; 11(11):1544-1560. PubMed ID: 28796930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
    Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T
    J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying and Validating of an Autophagy-Related Gene Signature for the Prediction of Early Relapse in Breast Cancer.
    Min Y; Feng Y; Luo H; Hu D; Wei X; He D; Yin G; Fan S
    Front Endocrinol (Lausanne); 2022; 13():824362. PubMed ID: 35250881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
    Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
    Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
    PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy.
    Su Q; Liu Z; Chen C; Gao H; Zhu Y; Wang L; Pan M; Liu J; Yang X; Tian J
    Cancer Med; 2021 Sep; 10(18):6492-6502. PubMed ID: 34453418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a novel mRNA signature for predicting early relapse in non-small cell lung cancer.
    Lin J; Weng J; Lin S; Lin C; Huang J; Zhang C; Zhang S; Dong C; Ji H; Ke X
    Jpn J Clin Oncol; 2021 Aug; 51(8):1277-1286. PubMed ID: 34037221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor microenvironment derived signature predicting relapse-free survival in I-III cancer and preliminary experiment verification.
    Zhang Z; Wu Q; Zhu D; He G; Feng Q; Xu J
    Int Immunopharmacol; 2021 Feb; 91():107243. PubMed ID: 33321467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A machine learning-based prognostic predictor for stage III colon cancer.
    Jiang D; Liao J; Duan H; Wu Q; Owen G; Shu C; Chen L; He Y; Wu Z; He D; Zhang W; Wang Z
    Sci Rep; 2020 Jun; 10(1):10333. PubMed ID: 32587295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study.
    Zheng P; Chen Q; Li J; Jin C; Kang L; Chen D
    J Surg Res; 2020 Jan; 245():475-482. PubMed ID: 31446189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.